NovaBay Pharmaceuticals (NYSEMKT:NBY) stock is falling hard on Thursday after the eyecare and wound care company announced results from its annual shareholder meeting. Included among the proposals in the annual shareholder meeting was a reverse stock split. Traders voted in favor of allowing the company's Board of Directors to enact a reverse split of NBY shares. Following that, NovaBay Pharmaceuticals announced that its Board has approved a one-for-35 reverse stock split for NBY. This will combine 35 share ...